Related Experiment Videos
Further studies on the biological characteristics of an endogenous colon mitosis inhibitor: comparison with some
1Institute of Pathology, Rikshospitalet, Oslo, Norway.
Abstract:
Previous work indicates that the colonic epithelial cell proliferation in mice is reversibly inhibited by the tripeptide pGlu-His-GlyOH found in aqueous extracts of the intestine. In the present study we examined the possible tissue specificity of the colon mitosis inhibitor. The mitotic rate in the small intestine, epidermis and forestomach in mice was registered after a single i.p. injection of the tripeptide. A significantly reduced rate of cell renewal was found at 18 h in the epidermis whereas no inhibition was observed in the forestomach or ileal epithelium. To investigate whether the amino acid sequence of the tripeptide is essential for the inhibitory effect, three structurally related bioactive peptides were tested and compared to the effect of CMI. CMI showed a bell-shaped dose-response relationship as previously shown, whereas the mitotic rate was not reduced in the colonic epithelium after treatment with either an epidermal mitosis inhibitory pentapeptide, or the dipeptide pGlu-GlyOH, or an analogue of luteinizing hormone-releasing hormone. The efficacy of the tripeptide was dependent on the basal rate of cell renewal in the colonic epithelium. When the tripeptide was given at the circadian nadir of cell proliferation a delayed reduction of proliferative activity was observed at 6 h after treatment, whereas treatment when the rate of cell proliferation was at its circadian zenith gave an immediate mitotic inhibition.
Insights
The tripeptide pGlu-His-GlyOH inhibits colonic epithelial cell proliferation in mice. Its efficacy is tissue-specific, primarily affecting the colon and epidermis, and depends on the cell renewal rate.
Area of Science:
- Gastroenterology
- Cell Biology
- Pharmacology
Background:
- The tripeptide pGlu-His-GlyOH, found in intestinal extracts, has been shown to inhibit colonic epithelial cell proliferation.
- Understanding the tissue specificity and mechanism of this colon mitosis inhibitor (CMI) is crucial for potential therapeutic applications.
Purpose of the Study:
- To investigate the tissue specificity of the colon mitosis inhibitor (CMI).
- To determine if the amino acid sequence of the tripeptide is essential for its inhibitory effect.
- To explore the influence of the basal cell renewal rate on CMI efficacy.
Main Methods:
- Mice were injected with the tripeptide and the mitotic rate in the small intestine, epidermis, and forestomach was measured.
- Structurally related peptides were tested for their effect on colonic epithelial cell proliferation.
- The timing of CMI administration relative to the circadian rhythm of cell proliferation was analyzed.
Main Results:
- CMI significantly reduced cell renewal in the epidermis but not in the forestomach or ileal epithelium.
- The inhibitory effect was specific to the tripeptide pGlu-His-GlyOH; related peptides did not inhibit colonic mitosis.
- CMI efficacy was dependent on the basal cell proliferation rate, with immediate inhibition at the zenith and delayed inhibition at the nadir of the circadian cycle.
Conclusions:
- The tripeptide pGlu-His-GlyOH acts as a specific colon mitosis inhibitor with some effect on epidermal cell renewal.
- The precise amino acid sequence is critical for the inhibitory activity.
- The timing of CMI administration relative to the circadian rhythm of cell proliferation influences its efficacy.